Association of plasma resistin levels with coronary heart disease in women

被引:96
作者
Pischon, T
Bamberger, CM
Kratzsch, J
Zyriax, BC
Algenstaedt, P
Boeing, H
Windler, E
机构
[1] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany
[2] Univ Hamburg Hosp, Dept Internal Med, D-2000 Hamburg, Germany
[3] Univ Leipzig, Inst Lab Med, Clin Chem & Mol Diagnost, D-7010 Leipzig, Germany
来源
OBESITY RESEARCH | 2005年 / 13卷 / 10期
关键词
epidemiology; coronary heart disease; adipokine; risk factor; inflammation;
D O I
10.1038/oby.2005.215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the association between plasma resistin levels and the presence of coronary heart disease (CHD) in women. Research Methods and Procedures: Plasma resistin levels were measured in a case-control study including 185 women with angiographically confirmed CHD and 227 population-based female controls from the Coronary Risk Factors for Atherosclerosis in Women (CORA) study. Results: After adjustment for age, smoking, family history of myocardial infarction, retirement, education, physical activity, menopausal status, hormone replacement use, BMI, hypertension, diabetes, and dyslipidemia, the odds ratio for CHD for women in the highest compared with lowest quintile of plasma resistin levels was 3.19 (95% confidence interval, 1.44 to 7.10; p log trend, 0.001). After additional adjustment for plasma C-reactive protein levels, this association was substantially attenuated and no longer significant (odds ratio, 1.80; 95% confidence interval, 0.69 ti 4.69; p trend = 0.23). Discussion: These results suggest that plasma resistin levels are significantly associated with the presence of CHD in women; however, this association can largely be explained by concomitant inflammatory processes. Further studies are needed to determine the causal role of resistin in the development of CHD in humans.
引用
收藏
页码:1764 / 1771
页数:8
相关论文
共 34 条
  • [1] Correlation between serum resistin level and adiposity in obese individuals
    Azuma, K
    Katsukawa, F
    Oguchi, S
    Murata, M
    Yamazaki, H
    Shimada, A
    Saruta, T
    [J]. OBESITY RESEARCH, 2003, 11 (08): : 997 - 1001
  • [2] Inflammatory bio-markers and cardiovascular risk prediction
    Blake, GJ
    Ridker, PM
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 252 (04) : 283 - 294
  • [3] Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
    Bonora, E
    Saggiani, F
    Targher, G
    Zenere, MB
    Alberiche, M
    Monauni, T
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2000, 23 (01) : 57 - 63
  • [4] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] Serum resistin (FIZZ3) protein is increased in obese humans
    Degawa-Yamauchi, M
    Bovenkerk, JE
    Juliar, BE
    Watson, W
    Kerr, K
    Jones, R
    Zhu, QH
    Considine, RV
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) : 5452 - 5455
  • [7] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [8] Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes
    Fujinami, A
    Obayashi, H
    Ohta, K
    Ichimura, T
    Nishimura, M
    Matsui, H
    Kawahara, Y
    Yamazaki, M
    Ogata, M
    Hasegawa, G
    Nakamura, N
    Yoshikawa, T
    Nakano, K
    Ohta, M
    [J]. CLINICA CHIMICA ACTA, 2004, 339 (1-2) : 57 - 63
  • [9] Effect of metformin on adipose tissue resistin expression in db/db mice
    Fujita, H
    Fujishima, H
    Morii, T
    Koshimura, J
    Narita, T
    Kakei, M
    Ito, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (03) : 345 - 349
  • [10] Expression of resistin in the adipose tissue is modulatedby various factors including peroxisome proliferator-activated receptor α
    Fukui, Y
    Motojima, K
    [J]. DIABETES OBESITY & METABOLISM, 2002, 4 (05) : 342 - 345